The Effect of Long-Term Second-Generation Antipsychotics Use on the Metabolic Syndrome Parameters in Jordanian Population
<i>Objectives:</i> The aim of this study was to determine the incidence of metabolic syndrome in patients treated with second-generation antipsychotics (SGAs). <i>Methods:</i> In this retrospective study, we reviewed patients’ electronic medical records (EMRs) of al...
Main Authors: | Osama Abo Alrob, Sayer Alazzam, Karem Alzoubi, Mohammad B. Nusair, Haneen Amawi, Reema Karasneh, Abeer Rababa’h, Mohammad Nammas |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2019-06-01
|
Series: | Medicina |
Subjects: | |
Online Access: | https://www.mdpi.com/1010-660X/55/7/320 |
Similar Items
-
Pharmacogenetics and Schizophrenia—Can Genomics Improve the Treatment with Second-Generation Antipsychotics?
by: Olga Płaza, et al.
Published: (2022-12-01) -
Can atypical antipsychotic drugs cause hepatotoxicity?
by: R. André, et al.
Published: (2021-04-01) -
Short-term efficacy and safety of lurasidone versus placebo in antipsychotic-naïve versus previously treated adolescents with an acute exacerbation of schizophrenia
by: Christoph U. Correll, et al.
Published: (2022-01-01) -
Atypical antipsychotics for delirium in hospitalized patients
by: Daniza Belén Bilicic Ubierna, et al.
Published: (2021-05-01) -
Myoclonic seizures induced by antipsychotic drugs: A case series and literature review (eng)
by: Taylan Altıparmak, et al.
Published: (2022-05-01)